{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:42:49Z","timestamp":1791308569844,"version":"4.3.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,5]]},"DOI":"10.7759\/cureus.33390","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T13:48:28Z","timestamp":1672926508000},"source":"Crossref","is-referenced-by-count":8,"title":["Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes"],"prefix":"10.7759","author":[{"given":"Sakshi Y","family":"Layacha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia A","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(03)00734-9","article-title":"The importance of insulin resistance in polycystic ovary syndrome","volume":"80","author":"Goodarzi MO","year":"2003","unstructured":"Goodarzi MO, Korenman SG. The importance of insulin resistance in polycystic ovary syndrome. Fertil Steril . 2003, 80:255-8. 10.1016\/S0015-0282(03)00734-9","journal-title":"Fertil Steril"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1514916","article-title":"Clinical practice. Polycystic ovary syndrome","volume":"375","author":"McCartney CR","year":"2016","unstructured":"McCartney CR, Marshall JC. Clinical practice. Polycystic ovary syndrome. N Engl J Med. 2016, 375:54-64. 10.1056\/NEJMcp1514916","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi MO","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011, 7:219-31. 10.1038\/nrendo.2010.217","journal-title":"Nat Rev Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.02.011","article-title":"Ontogeny of the ovary in polycystic ovary syndrome","volume":"100","author":"Dumesic DA","year":"2013","unstructured":"Dumesic DA, Richards JS. Ontogeny of the ovary in polycystic ovary syndrome. Fertil Steril. 2013, 100:23-38. 10.1016\/j.fertnstert.2013.02.011","journal-title":"Fertil Steril"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004526","article-title":"Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: a meta-analysis","volume":"95","author":"Zeng XL","year":"2016","unstructured":"Zeng XL, Zhang YF, Tian Q, Xue Y, An RF. Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: a meta-analysis. Medicine (Baltimore). 2016, 95:e4526. 10.1097\/MD.0000000000004526","journal-title":"Medicine (Baltimore)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.11.5232","article-title":"Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation","volume":"83","author":"Willis DS","year":"1998","unstructured":"Willis DS, Watson H, Mason HD, Galea R, Brincat M, Franks S. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab. 1998, 83:3984-91. 10.1210\/jcem.83.11.5232","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.3.7318","article-title":"Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries","volume":"86","author":"Jakimiuk AJ","year":"2001","unstructured":"Jakimiuk AJ, Weitsman SR, Navab A, Magoffin DA. Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J Clin Endocrinol Metab. 2001, 86:1318-23. 10.1210\/jcem.86.3.7318","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gan082","article-title":"Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients","volume":"15","author":"Kenigsberg S","year":"2009","unstructured":"Kenigsberg S, Bentov Y, Chalifa-Caspi V, Potashnik G, Ofir R, Birk OS. Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients. Mol Hum Reprod. 2009, 15:89-103. 10.1093\/molehr\/gan082","journal-title":"Mol Hum Reprod"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh873","article-title":"Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism","volume":"20","author":"Eldar-Geva T","year":"2005","unstructured":"Eldar-Geva T, Margalioth EJ, Gal M, et al.. Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod. 2005, 20:1814-9. 10.1093\/humrep\/deh873","journal-title":"Hum Reprod"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0907","article-title":"Anti-m\u00fcllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries","volume":"90","author":"Stubbs SA","year":"2005","unstructured":"Stubbs SA, Hardy K, Da Silva-Buttkus P, et al.. Anti-m\u00fcllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. J Clin Endocrinol Metab. 2005, 90:5536-43. 10.1210\/jc.2005-0907","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.08.015","article-title":"Anti-M\u00fcllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells","volume":"96","author":"Pellatt L","year":"2011","unstructured":"Pellatt L, Rice S, Dilaver N, et al.. Anti-M\u00fcllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells. Fertil Steril. 2011, 96:1246-51.e1. 10.1016\/j.fertnstert.2011.08.015","journal-title":"Fertil Steril"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1231","article-title":"Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome","volume":"93","author":"Catteau-Jonard S","year":"2008","unstructured":"Catteau-Jonard S, Jamin SP, Leclerc A, Gonzal\u00e8s J, Dewailly D, di Clemente N. Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008, 93:4456-61. 10.1210\/jc.2008-1231","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp","volume":"28","author":"Stepto NK","year":"2013","unstructured":"Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod. 2013, 28:777-84. 10.1093\/humrep\/des463","journal-title":"Hum Reprod"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0782","article-title":"Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women","volume":"164","author":"Tosi F","year":"2011","unstructured":"Tosi F, Negri C, Brun E, et al.. Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women. Eur J Endocrinol. 2011, 164:197-203. 10.1530\/EJE-10-0782","journal-title":"Eur J Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2006.05.006","article-title":"Molecular mechanisms of insulin resistance in polycystic ovary syndrome","volume":"12","author":"Diamanti-Kandarakis E","year":"2006","unstructured":"Diamanti-Kandarakis E, Papavassiliou AG. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med. 2006, 12:324-32. 10.1016\/j.molmed.2006.05.006","journal-title":"Trends Mol Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v13.i1.5","article-title":"Polycystic ovary syndrome and type 2 diabetes mellitus: a state-of-the-art review","volume":"13","author":"Livadas S","year":"2022","unstructured":"Livadas S, Anagnostis P, Bosdou JK, Bantouna D, Paparodis R. Polycystic ovary syndrome and type 2 diabetes mellitus: a state-of-the-art review. World J Diabetes. 2022, 13:5-26. 10.4239\/wjd.v13.i1.5","journal-title":"World J Diabetes"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/BF02980074","article-title":"Insulin receptor substrate proteins and diabetes","volume":"27","author":"Lee YH","year":"2004","unstructured":"Lee YH, White MF. Insulin receptor substrate proteins and diabetes. Arch Pharm Res. 2004, 27:361-70. 10.1007\/BF02980074","journal-title":"Arch Pharm Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.11.003","article-title":"Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity","volume":"502","author":"Zeng X","year":"2020","unstructured":"Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020, 502:214-21. 10.1016\/j.cca.2019.11.003","journal-title":"Clin Chim Acta"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20160393","article-title":"Awareness of lifestyle modification in females diagnosed with polycystic ovarian syndrome in India: explorative study","volume":"470","author":"Pitchai P","year":"2016","unstructured":"Pitchai P, S R S, Anil P. Awareness of lifestyle modification in females diagnosed with polycystic ovarian syndrome in India: explorative study. Int. j. reprod. contracept. obstet. gynecol.. 2016, 470:6. 10.18203\/2320-1770.ijrcog20160393","journal-title":"Int. j. reprod. contracept. obstet. gynecol."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7292(01)00442-8","article-title":"Polycystic ovarian syndrome (PCOS) and insulin resistance","volume":"74","author":"Park KH","year":"2001","unstructured":"Park KH, Kim JY, Ahn CW, Song YD, Lim SK, Lee HC. Polycystic ovarian syndrome (PCOS) and insulin resistance. Int J Gynaecol Obstet. 2001, 74:261-7. 10.1016\/S0020-7292(01)00442-8","journal-title":"Int J Gynaecol Obstet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz R","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, et al.. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009, 91:456-88. 10.1016\/j.fertnstert.2008.06.035","journal-title":"Fertil Steril"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(05)70073-6","article-title":"Insulin action in the polycystic ovary syndrome","volume":"28","author":"Dunaif A","year":"1999","unstructured":"Dunaif A. Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin North Am. 1999, 28:341-59. 10.1016\/S0889-8529(05)70073-6","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis","volume":"327(7421)","author":"J M Lord","year":"2003","unstructured":"J M Lord, I H K Flight and R J Norman, professor. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. The BMJ. 2003, 327(7421):951. 10.1136\/bmj.327.7421.951","journal-title":"The BMJ"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(97)00296-2","article-title":"Menstrual cyclicity after metformin therapy in polycystic ovary syndrome","volume":"90","author":"Vel\u00e1zquez M E","year":"1997","unstructured":"Vel\u00e1zquez M E, Acosta A, Mendoza SG. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet. Gynecol.. 1997, 90:392-5. 10.1016\/S0029-7844(97)00296-2","journal-title":"Obstet. Gynecol."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80057-6","article-title":"Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.","volume":"98","author":"Dunaif A","year":"1995","unstructured":"Dunaif A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. . Am. J. Med.. 1995, 98:33-9. 10.1016\/S0002-9343(99)80057-6","journal-title":"Am. J. Med."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.00884.x","article-title":"The prevalence of polycystic ovaries in women with type 2 diabetes mellitus","volume":"52","author":"Conn JJ","year":"2000","unstructured":"Conn JJ, Jacobs HS, Conway GS. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clin Endocrinol (Oxf). 2000, 52:81-6. 10.1046\/j.1365-2265.2000.00884.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis E","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012, 33:981-1030. 10.1210\/er.2011-1034","journal-title":"Endocr Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(02)00612-4","article-title":"The role of lifestyle modification in polycystic ovary syndrome","volume":"13","author":"Norman RJ","year":"2002","unstructured":"Norman RJ, Davies MJ, Lord J, Moran LJ. The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab. 2002, 13:251-7. 10.1016\/S1043-2760(02)00612-4","journal-title":"Trends Endocrinol Metab"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1097\/00001703-199106000-00004","article-title":"Polycystic ovary syndrome: evolution of a concept","volume":"3","author":"Ruutiainen K","year":"1991","unstructured":"Ruutiainen K, Sepp\u00e4l\u00e4 M. Polycystic ovary syndrome: evolution of a concept. Curr Opin Obstet Gynecol. 1991, 3:326-35.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.coemr.2020.02.014","article-title":"Medical treatment and comorbidity in polycystic ovary syndrome: an updated review","volume":"12","author":"Glintborg D","year":"2020","unstructured":"Glintborg D, Andersen M. Medical treatment and comorbidity in polycystic ovary syndrome: an updated review. Curr Opin Endocrinol Diabetes Obes. 2020, 12:33-40. 10.1016\/j.coemr.2020.02.014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(99)00468-9","article-title":"Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity","volume":"73","author":"Mather KJ","year":"2000","unstructured":"Mather KJ, Kwan F, Corenblum B. Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertil Steril. 2000, 73:150-6. 10.1016\/s0015-0282(99)00468-9","journal-title":"Fertil Steril"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v5.i2.128","article-title":"Recent advances in the molecular genetics of type 2 diabetes mellitus","volume":"5","author":"Brunetti A","year":"2014","unstructured":"Brunetti A, Chiefari E, Foti D. Recent advances in the molecular genetics of type 2 diabetes mellitus. World J Diabetes. 2014, 5:128-40. 10.4239\/wjd.v5.i2.128","journal-title":"World J Diabetes"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-017-0956-2","article-title":"Cardiometabolic risk in PCOS: more than a reproductive disorder","volume":"17","author":"Torchen LC","year":"2017","unstructured":"Torchen LC. Cardiometabolic risk in PCOS: more than a reproductive disorder. Curr Diab Rep. 2017, 17:137. 10.1007\/s11892-017-0956-2","journal-title":"Curr Diab Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-nutr-071714-034434","article-title":"Health benefits of long-term weight-loss maintenance","volume":"35","author":"Rueda-Clausen CF","year":"2015","unstructured":"Rueda-Clausen CF, Ogunleye AA, Sharma AM. Health benefits of long-term weight-loss maintenance. Annu Rev Nutr. 2015, 35:475-516. 10.1146\/annurev-nutr-071714-034434","journal-title":"Annu Rev Nutr"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/nu12041066","article-title":"Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases","volume":"12","author":"Mirabelli M","year":"2020","unstructured":"Mirabelli M, Chiefari E, Arcidiacono B, et al.. Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases. Nutrients. 2020, 12:1066. 10.3390\/nu12041066","journal-title":"Nutrients"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/116949-women-with-polycystic-ovary-syndrome-a-review-of-susceptibility-to-type-2-diabetes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:42Z","timestamp":1707508062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/116949-women-with-polycystic-ovary-syndrome-a-review-of-susceptibility-to-type-2-diabetes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,5]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.33390","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,5]]}}}